Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background: Celiac disease (CD) is an autoimmune enteropathy triggered by the ingestion of gluten. Gluten-sensitive individuals (GS) cannot tolerate gluten and may develop gastrointestinal symptoms similar to those in CD, but the overall clinical picture is generally less severe and is not accompanied by the concurrence of tissue transglutaminase autoantibodies or autoimmune comorbidities. By studying and comparing mucosal expression of genes associated with intestinal barrier function, as well as innate and adaptive immunity in CD compared with GS, we sought to better understand the similarities and differences between these two gluten-associated disorders. Methods: CD, GS and healthy, gluten-tolerant individuals were enrolled in this study. Intestinal permeability was evaluated using a lactulose and mannitol probe, and mucosal biopsy specimens were collected to study the expression of genes involved in barrier function and immunity. Results: Unlike CD, GS is not associated with increased intestinal permeability. In fact, this was significantly reduced in GS compared with controls (P = 0.0308), paralleled by significantly increased expression of claudin (CLDN) 4 (P = 0.0286). Relative to controls, adaptive immunity markers interleukin (IL)-6 (P = 0.0124) and IL-21 (P = 0.0572) were expressed at higher levels in CD but not in GS, while expression of the innate immunity marker Toll-like receptor (TLR) 2 was increased in GS but not in CD (P = 0.0295). Finally, expression of the T-regulatory cell marker FOXP3 was significantly reduced in GS relative to controls (P = 0.0325) and CD patients (P = 0.0293). Conclusions: This study shows that the two gluten-associated disorders, CD and GS, are different clinical entities, and it contributes to the characterization of GS as a condition associated with prevalent gluten-induced activation of innate, rather than adaptive, immune responses in the absence of detectable changes in mucosal barrier function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some patients with IBS lack tissue transglutaminase antibodies or histological markers of coeliac disease yet still respond symptomatically to a gluten-free diet.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [158]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, P. H. R., & Jones, R. (2006) · Cited by 2,453
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154 · cited 1×
“Different combinations of TLRs are expressed in hematopoietic cells and nonhematopoietic cells such as intestinal epithelial cells [42-44].”
BackgroundFuruse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,095 · cited 2×
“For instance, CLDN1 and CLDN4 are postulated to decrease, whereas CLDN2 is postulated to increase TJ-dependent permeability [35].”
BackgroundIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 1×
“This involves the mucosal recruitment and activation of Th1 and Th17 clones and the production of Th1- and Th17-associated cytokines, namely, IFN-g and IL-17A, which contribute to disrupting barrier function and initiating tissue damage [16,18-21,41].”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542 · cited 7×
“Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.”
BackgroundInfluentialSteinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376 · cited 2×
“This involves the mucosal recruitment and activation of Th1 and Th17 clones and the production of Th1- and Th17-associated cytokines, namely, IFN-γ and IL17A, which contribute to disrupting barrier function and initiating tissue damage [16, 18-21, 41].”
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150 · cited 1×
“Different combinations of TLRs are expressed in hematopoietic cells and nonhematopoietic cells such as intestinal epithelial cells [42-44].”
BackgroundAlterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634 · cited 1×
“Increased intestinal permeability is thought to be an early biological change that precedes the onset of several autoimmune diseases [32-34].”
BackgroundVan Itallie, C., Rahner, C., & Anderson, J. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12464 · Cited by 601 · cited 1×
“associated with marked differences in mucosal barrier function and with apparent differences in the expression of CLDN4, which encodes for a critical TJ component [38].”
BackgroundBrandtzaeg, P., Halstensen, T. S., Kett, K., Krajči, P., Kvale, D., Rognum, T. O., Scott, H., & Sollid, L. M. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90406-x · Cited by 550 · cited 1×
“These are generally defined as gluten sensitivity (GS) [2-5].”
Backgroundde Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181dcc4a5 · Cited by 546 · cited 1×
“Similarly, higher than expected titers of AGAs, signs and symptoms associated with non-CD gluten sensitivity, have also been reported for schizophrenia [39] and autism spectrum disorders [40].”
BackgroundSelf-citationStructural basis for physiological regulation of paracellular pathways in intestinal epithelia
Madara, J. L., & Pappenheimer, J. R. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209147 · Cited by 513 · cited 1×
“As recently shown, CLDNs are integral TJ components that are critical for maintaining cell-cell adhesion in epithelial monolayers [35-37].”
BackgroundDrago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M., Iacono, G., Carroccio, A., D'Agate, C., Not, T., et al. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500235334 · Cited by 502 · cited 1×
“Gliadin has agglutinating activity, reduces F-actin content, inhibits cell growth, induces apoptosis, alters redox equilibrium and causes a rearrangement of the cytoskeleton through the zonulin pathway and the loss of tight junction (TJ) competence in the gastrointestinal mucosa [6-9].”
BackgroundSelf-citationThe claudin gene family: expression in normal and neoplastic tissues
Hewitt, K. J., Agarwal, R., & Morin, P. J. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-186 · Cited by 497 · cited 1×
“As recently shown, CLDNs are integral TJ components that are critical for maintaining cell-cell adhesion in epithelial monolayers [35-37].”
BackgroundFasano, A., & Shea-Donohue, T. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0259 · Cited by 484 · cited 1×
“Increased intestinal permeability is thought to be an early biological change that precedes the onset of several autoimmune diseases [32-34].”
BackgroundSelf-citationGluten sensitivity: from gut to brain
Hadjivassiliou, M., Sanders, D. S., Grünewald, R. A., Woodroofe, N., Boscolo, S., & Aeschlimann, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70290-x · Cited by 404
Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity
Verdu, E. F., Armstrong, D., & Murray, J. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.188 · Cited by 283 · cited 1×
“In itself, the absence of autoantibodies and intestinal lesions does not rule out the intrinsic toxicity of gluten, whose intake, even in non-CD individuals, has been associated with damage to other tissues, organs and systems besides the intestine [6,30,31].”
BackgroundSapone, A., Lammers, K. M., Mazzarella, G., Mikhailenko, I., Cartenì, M., Casolaro, V., & Fasano, A. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000260087 · Cited by 241 · cited 8×
“Intestinal gene expression was measured by quantitative real-time polymerase chain reaction (qPCR) assay as described previously [15].”
BackgroundMethodResultInfluentialSelf-citationThomas, K. E., Sapone, A., Fasano, A., & Vogel, S. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2512 · Cited by 231 · cited 1×
“It has been reported that the expression of Toll-like receptor 1 (TLR1), TLR2, and TLR4 is increased in the small intestine mucosa of CD patients, lending support to the idea that innate immune phenomena may precede and/or accompany the progression of CD and other autoimmune conditions [22-24].”
BackgroundSelf-citationZanoni, G., Navone, R., Lunardi, C., Tridente, G., Bason, C., Sivori, S., Beri, R., Dolcino, M., Valletta, E., Corrocher, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030358 · Cited by 224 · cited 1×
“It has been reported that the expression of Toll-like receptor 1 (TLR1), TLR2, and TLR4 is increased in the small intestine mucosa of CD patients, lending support to the idea that innate immune phenomena may precede and/or accompany the progression of CD and other autoimmune conditions [22-24].”
BackgroundA prospective study of the incidence of childhood celiac disease
Hoffenberg, E. J., MacKenzie, T., Barriga, K. J., Eisenbarth, G. S., Bao, F., Haas, J. E., Erlich, H., Bugawan, T. L., Sokol, R. J., Taki, I., et al. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00282-8 · Cited by 216 · cited 1×
“These are generally defined as gluten sensitivity (GS) [2-5].”
BackgroundForsberg, G., Hernell, O., Melgar, S., Israelsson, A., Hammarström, S., & Hammarström, M. (2002) · Gastroenterology · doi:10.1053/gast.2002.35355 · Cited by 183 · cited 1×
“These findings, quite opposite to our starting hypothesis but perhaps in line with earlier reports on CD and other conditions [27,28], may suggest a reduced level of activation and/or recruitment of Treg cells in the GS small intestine mucosa relative to gluten-tolerant controls.”
ResultCatassi, C., & Fasano, A. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32830edc1e · Cited by 180
Self-citationMorón, B., Bethune, M. T., Comino, I., Manyani, H., Ferragud, M., López, M. C., Cebolla, Á., Khosla, C., & Sousa, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002294 · Cited by 175 · cited 1×
“Gliadin has agglutinating activity, reduces F-actin content, inhibits cell growth, induces apoptosis, alters redox equilibrium and causes a rearrangement of the cytoskeleton through the zonulin pathway and the loss of tight junction (TJ) competence in the gastrointestinal mucosa [6-9].”
BackgroundCascella, N. G., Kryszak, D., Bhatti, B., Gregory, P., Kelly, D. L., Mc Evoy, J. P., Fasano, A., & Eaton, W. W. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp055 · Cited by 171 · cited 1×
“Similarly, higher than expected titers of AGAs, signs and symptoms associated with non-CD gluten sensitivity, have also been reported for schizophrenia [39] and autism spectrum disorders [40].”
BackgroundSelf-citationGreen, P. H. R., Rostami, K., & Marsh, M. N. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.006 · Cited by 157
Characterization of IL-17A–Producing Cells in Celiac Disease Mucosa
Monteleone, I., Sarra, M., Blanco, G. D. V., Paoluzi, O. A., Franzè, E., Fina, D., Fabrizi, A., MacDonald, T. T., Pallone, F., & Monteleone, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901919 · Cited by 136 · cited 2×
“Mucosal expression of adaptive immunity-related cytokines A number of studies have documented the gluten-dependent rise in the systemic and mucosal expression of cytokines associated with Th1 and Th17 adaptive responses in CD [16-19].”
BackgroundThe role of innate signaling in the homeostasis of tolerance and immunity in the intestine
Wells, J. M., Loonen, L. M. P., & Karczewski, J. M. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.008 · Cited by 134 · cited 1×
“Different combinations of TLRs are expressed in hematopoietic cells and nonhematopoietic cells such as intestinal epithelial cells [42-44].”
BackgroundT H 17 (and T H 1) signatures of intestinal biopsies of CD patients in response to gliadin
Castellanos–Rubio, A., Santín, I., Irastorza, I., Castaño, L. A., Vitoria, J. C., & Bilbao, J. R. (2009) · Autoimmunity · doi:10.1080/08916930802350789 · Cited by 107 · cited 2×
“A number of studies have documented the gluten-dependent rise in the systemic and mucosal expression of cytokines associated with Th1 and Th17 adaptive responses in CD [16-19].”
BackgroundThe natural history of gluten sensitivity: defining, refining and re-defining
Marsh, M. N. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a068990 · Cited by 99 · cited 1×
“Biopsy specimens were staged by histology according to the Marsh classification [12,13].”
MethodInterleukin-23 and Th17 Cells in the Control of Gut Inflammation
Monteleone, I., Pallone, F., & Monteleone, G. (2009) · Mediators of Inflammation · doi:10.1155/2009/297645 · Cited by 95 · cited 2×
“A number of studies have documented the gluten-dependent rise in the systemic and mucosal expression of cytokines associated with Th1 and Th17 adaptive responses in CD [16-19].”
BackgroundIncreased Mucosal Expression of Toll‐like Receptor (TLR)2 and TLR4 in Coeliac Disease
Szebeni, B., Veres, G., Dezsőfi, A., Rusai, K., Vannay, Á., Bokodi, G., Vásárhelyi, B., Korponay‐Szabó, I., Tulassay, T., & Arató, A. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318064514a · Cited by 93 · cited 1×
“It has been reported that the expression of Toll-like receptor 1 (TLR1), TLR2, and TLR4 is increased in the small intestine mucosa of CD patients, lending support to the idea that innate immune phenomena may precede and/or accompany the progression of CD and other autoimmune conditions [22-24].”
BackgroundMazzarella, G., Maglio, M., Paparo, F., Nardone, G., Stefanile, R., Greco, L., van de Wal, Y., Kooy, Y., Koning, F., Auricchio, S., et al. (2002) · Gut · doi:10.1136/gut.52.1.57 · Cited by 92 · cited 1×
“Immunostaining to identify intraepithelial lymphocytes (IELs) was performed as described elsewhere [14].”
MethodSelf-citationReefer, A. J., Satinover, S. M., Solga, M. D., Lannigan, J. A., Nguyen, J. T., Wilson, B. B., & Woodfolk, J. A. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.003 · Cited by 88
Anderson, L. A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.146 · Cited by 88
Coeliac disease: in vivo toxicity of the putative immunodominant epitope
Fraser, J., Engel, W., Ellis, H. J., Moodie, S. J., Pollock, E. L., Wieser, H., & Ciclitira, P. J. (2003) · Gut · doi:10.1136/gut.52.12.1698 · Cited by 83 · cited 1×
“Gliadin has agglutinating activity, reduces F-actin content, inhibits cell growth, induces apoptosis, alters redox equilibrium and causes a rearrangement of the cytoskeleton through the zonulin pathway and the loss of tight junction (TJ) competence in the gastrointestinal mucosa [6-9].”
BackgroundIntestinal Permeability: Clinical Correlates
Bjarnason, I., Peters, T. J., & Levi, A. J. (2008) · Digestive Diseases · doi:10.1159/000171140 · Cited by 72 · cited 1×
“Increased intestinal permeability is thought to be an early biological change that precedes the onset of several autoimmune diseases [32-34].”
BackgroundHarris, K. M., Fasano, A., & Mann, D. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4457 · Cited by 72 · cited 7×
“Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.”
BackgroundInfluentialSelf-citationVorobjova, T., Uibo, O., Heilman, K., Rägö, T., Honkanen, J. K., Vaarala, O., Tillmann, V., Ojakivi, I., & Uibo, R. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802624177 · Cited by 66 · cited 2×
“These findings, quite opposite to our starting hypothesis but perhaps in line with earlier reports on CD and other conditions [27,28], may suggest a reduced level of activation and/or recruitment of Treg cells in the GS small intestine mucosa relative to gluten-tolerant controls.”
ResultRegulatory T-Cell Function Is Impaired in Celiac Disease
Granzotto, M., Bo, S. D., Quaglia, S., Tommasini, A., Piscianz, E., Valencic, E., Ferrara, F., Martelossi, S., Ventura, A., & Not, T. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0501-x · Cited by 63 · cited 2×
“In contrast to earlier reports [25,26], the levels of expression of both FOXP3 and TGFB1 in CD patients did not differ significantly from those in DC (P = 0.”
BackgroundResultGeneroso, M., ROSA, M. D., Rosa, R. D., de Magistris, L., Secondulfo, M., Fiandra, R., Carratu, R., & Cartenı̀, M. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00766-3 · Cited by 57 · cited 2×
“In vivo permeability was determined by means of the lactulose/mannitol (LA/MA) test as previously described [11].”
BackgroundMethodSelf-citationAnalysis of Food Allergen Structures and Development of Foods for Allergic Patients
Tanabe, S. (2008) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70708 · Cited by 56 · cited 1×
“triggers the release of chemical mediators, such as histamine, from basophils and mast cells [1].”
BackgroundHansson, T., Ulfgren, A. ‐., Lindroos, E., Dannaeus, A., Dahlbom, I., & Klareskog, L. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01157.x · Cited by 48 · cited 1×
“However, at least as surprisingly, in several studies FOXP3 and other Tregexpressed molecules, such as TGFB1, have been found to be upregulated in the peripheral blood and intestinal mucosa of patients with CD and related conditions, for example, type 1 diabetes [28,45].”
Dolfini, E., Roncoroni, L., Elli, L., Fumagalli, C., Colombo, R., Ramponi, S., Forlani, F., & Bardella, M. T. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i48.7597 · Cited by 43 · cited 2×
“In itself, the absence of autoantibodies and intestinal lesions does not rule out the intrinsic toxicity of gluten, whose intake, even in non-CD individuals, has been associated with damage to other tissues, organs and systems besides the intestine [6,30,31].”
BackgroundTroncone, R., Bhatnagar, S., Butzner, D., Cameron, D. J. S., Hill, I. D., Hoffenberg, E. J., Mäki, M., Méndez, V., & de Jiménez, M. Z. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200406002-00005 · Cited by 30 · cited 2×
“As recently reported by our group [15], histology revealed a normal to mildly inflamed mucosa (Marsh stage 0 or 1) in GS patients, while all CD patients showed partial or subtotal villous atrophy with crypt hyperplasia according to the ESPGHAN criteria [10].”
MethodResultGarrote, J. A., Arranz, E. M., Gómez‐González, E., Leon, A. J., Farré, C., Calvo, C. M., Bernardo, D., Fernández-Salazar, L. I., & Blanco-Quirós, A. (2005) · Allergologia et Immunopathologia · doi:10.1157/13080926 · Cited by 24 · cited 1×
“earlier reports [25, 26], the levels of expression of both FOXP3 and TGFB1 in CD patients did not differ significantly from those in DC (P = 0.”
ResultHeterogeneity of Celiac Disease: Clinical, Pathological, Immunological, and Genetic
Ferguson, A., Gillett, H. R., Humphreys, K., & Kingstone, K. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11115.x · Cited by 21 · cited 1×
“In the past few years, though, it has become apparent that “classic” CD represents the tip of the iceberg of an overall disease burden [4,29].”
BackgroundTison, C. (1960) · PubMed · Cited by 7
Cited by
The Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
Self-citationMedicine & science in sports & exercise
(1994) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(94)92575-5 · Cited by 1,303
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
Sapone, A., Bai, J. C., Ciacci, C., Dolinsek, J., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Rostami, K., Sanders, D. S., Schumann, M., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-13 · Cited by 1,140
“Therefore, it is not surprising that during the past 50 years we have witnessed an ‘epidemic’ of CD [68,69] and the surging of new gluten-related disorders, including the most recently described GS [44,62].”
BackgroundSelf-citationIntestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Human Intestinal Barrier Function in Health and Disease
König, J., Wells, J., Cani, P. D., García-Ródenas, C. L., MacDonald, T., Mercenier, A., Whyte, J., Troost, F., & Brummer, R.-J. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.54 · Cited by 780
“Sapone et al.126 did not find an increased intestinal permeability in the small bowel Clinical and Translational Gastroenterology of non-celiac gluten-sensitive individuals (n= 13) using the lactulose/mannitol test compared with dyspeptic controls (n=14), whereas celiac disease patients (n= 11) had a significantly inc…”
BackgroundInfluential
Metadata
- Authors
- Sapone, A., Lammers, K. M., Casolaro, V., Cammarota, M., Giuliano, M. T., De Rosa, M., Stefanile, R., Mazzarella, G., Tolone, C., Russo, M. I., Esposito, P., Ferraraccio, F., Cartenì, M., Riegler, G., de Magistris, L., & Fasano, A.
- Affiliations
- University of Maryland, Baltimore (US)
- University of Campania "Luigi Vanvitelli" (IT)
- Institute of Food Science (IT)
- Corresponding author
- Fasano, Alessio
- ORCID
- Venue
- BMC Medicine
- Published
- 2011-03-09
- Volume
- 9
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC3065425
- OpenAlex
- W2069634861
- Cited by
- 452
- References
- 48
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 11 · 2023: 8 · 2022: 20 · 2021: 36 · 2020: 36 · 2019: 35 · 2018: 31 · 2017: 39 · 2016: 36 · 2015: 58 · 2014: 39 · 2013: 38 · 2012: 30
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK078699)
- Topics
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Wheat and Barley Genetics and Pathology
- Keywords
- celiac disease, gluten sensitivity, intestinal permeability, intestinal barrier function, mucosal gene expression, claudin-4, interleukin-6, IL-21, TLR2, Foxp3, regulatory T cells, innate immunity, adaptive immunity, gluten
- MeSH terms
- Adult, Allergens, Celiac Disease, Female, Glutens, Humans, Hypersensitivity, Intestinal Mucosa, Male, Permeability, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.